SCHEMBL112189

SCHEMBL112189

CN1CCc2nc(NC(=O)c3ccccc3N3CCN(C(=O)CN4C=C5C=CCC(=O)C5C4)CC3)sc2C1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
F10 P00742 1/20 0.44
NPC1 O15118 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP2D6 P10635 1/20 0.40
HPGD P15428 1/20 0.40
CYP2C19 P33261 1/20 0.40
RAB9A P51151 1/20 0.40
ALDH1A1 P00352 2/20 0.40
KMT2A Q03164 2/20 0.40
USP2 O75604 1/20 0.40
ALOX15 P16050 1/20 0.40
CASP1 P29466 1/20 0.40
BRCA1 P38398 1/20 0.40
CASP7 P55210 1/20 0.40
HSD17B10 Q99714 1/20 0.40
KDM4E B2RXH2 2/20 0.39
MEN1 O00255 1/20 0.39
MAPT P10636 1/20 0.39
HTT P42858 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL112819 0.91 KDM4E (0.39) F10NPC1CYP1A2CYP2D6HPGD
SCHEMBL161641 0.78 F10 (0.48) F10NPC1CYP1A2CYP2D6HPGD
SCHEMBL113651 0.76 CXCR3 (0.51) F10NPC1CYP1A2CYP2D6HPGD
SCHEMBL109300 0.76 SCN10A (0.36) RAB9AALDH1A1KMT2AMAPTSMN1; SMN2
SCHEMBL112005 0.74 GRAMD1A (0.53) F10NPC1CYP1A2CYP2D6HPGD
SCHEMBL161011 0.71 ALDH1A1 (0.44) F10NPC1CYP1A2CYP2D6HPGD
SCHEMBL13077265 0.69 ROCK2 (0.43) F10NPC1CYP1A2CYP2D6HPGD
SCHEMBL112973 0.68 CXCR3 (0.53) NPC1CYP1A2HPGDCYP2C19RAB9A
SCHEMBL112526 0.67 F10 (0.47) F10NPC1CYP1A2CYP2D6HPGD
SCHEMBL8842998 0.67 NPC1 (0.66) F10NPC1CYP1A2CYP2D6HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2424858-A1 CXCR3 RECEPTOR ANTAGONISTS Boehringer Ingelheim International GmbH (DE) 2012-03-07 EP disclosed
WO-2010126851-A1 CXCR3 RECEPTOR ANTAGONISTS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-11-04 WO disclosed